SNX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.287900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.609600E-02
Normal-vs-Stage2
9.483700E-02
Normal-vs-Stage3
5.019800E-02
Normal-vs-Stage4
2.135000E-01
Stage1-vs-Stage2
5.998200E-01
Stage1-vs-Stage3
1.028410E-01
Stage1-vs-Stage4
6.377400E-01
Stage2-vs-Stage3
2.523400E-01
Stage2-vs-Stage4
9.597800E-01
Stage3-vs-Stage4
4.824800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.784300E-02
Normal-vs-AfricanAmerican
1.316000E-01
Normal-vs-Asian
7.958200E-02
Caucasian-vs-AfricanAmerican
6.902600E-01
Caucasian-vs-Asian
2.021000E-01
AfricanAmerican-vs-Asian
3.291800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.164000E-02
Normal-vs-Female
6.704000E-02
Male-vs-Female
4.572600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.332800E-01
Normal-vs-Age(41-60Yrs)
1.718810E-01
Normal-vs-Age(61-80Yrs)
4.554200E-02
Normal-vs-Age(81-100Yrs)
5.647900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.805000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.491000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.005800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.423200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.521800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.275900E-02
Normal-vs-Daily Drinker
7.869600E-02
Normal-vs-Weekly Drinker
1.783210E-01
Normal-vs-Occasional Drinker
3.595700E-02
Normal-vs-Social Drinker
3.956500E-02
Non Drinker-vs-Daily Drinker
7.173800E-01
Non Drinker-vs-Weekly Drinker
9.329200E-01
Non Drinker-vs-Occasional Drinker
8.215200E-01
Non Drinker-vs-Social Drinker
8.090600E-01
Daily Drinker-vs-Weekly Drinker
7.273400E-01
Daily Drinker-vs-Occasional Drinker
5.749600E-01
Daily Drinker-vs-Social Drinker
5.802200E-01
Weekly Drinker-vs-Occasional Drinker
9.265800E-01
Weekly Drinker-vs-Social Drinker
9.116800E-01
Occasional Drinker-vs-Social Drinker
9.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.753400E-01
Normal-vs-Grade 2
9.138800E-01
Normal-vs-Grade 3
8.926200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.198190E-02
Grade 1-vs-Grade 3
1.464000E-02
Grade 1-vs-Grade 4
9.753400E-01
Grade 2-vs-Grade 3
5.533000E-01
Grade 2-vs-Grade 4
9.138800E-01
Grade 3-vs-Grade 4
8.926200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.004000E-01
Normal-vs-NonDiabetic
5.590400E-02
Diabetic-vs-NonDiabetic
9.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.371830E-01
Normal-vs-NoPancreatitis
6.627700E-02
Pancreatitis-vs-NoPancreatitis
2.107400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.796190E-02
Normal-vs-N1
1.186640E-01
N0-vs-N1
8.353900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.772000E-02
Normal-vs-TP53-NonMutant
3.556400E-02
TP53-Mutant-vs-TP53-NonMutant
1.534360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
